Jeroen A J Thijs

Title: Jeroen A J Thijs - Innovator in Doppler Radar Technology

Introduction

Jeroen A J Thijs is an accomplished inventor based in Waldfeucht, Germany. He has made significant contributions to the field of radar technology, particularly with regard to medical applications. His innovative approach has resulted in the development of a novel invention that enhances the functionality of Doppler radar heart sensors.

Latest Patents

Thijs holds a patent for "Automatic transmission power adjustment for Doppler radar." This invention outlines a Doppler radar heart sensor that includes components such as a radar signal emitter, a radar signal receiver, a signal pattern matcher, and a transmission power adjuster. The signal pattern matcher analyzes the received radar signal, comparing it with established signal patterns, and issues an indication signal when a high similarity is detected. The transmission power adjuster then modifies the power delivered to the radar signal emitter in response to the output from the signal pattern matcher, thereby optimizing the radar's performance.

Career Highlights

Jeroen A J Thijs is currently employed at Koninklijke Philips Corporation N.V., a global leader in health technology. His work at Philips has positioned him at the forefront of innovative healthcare solutions. With his unique skill set, he has taken on challenges that require a blend of engineering and medical expertise.

Collaborations

Thijs collaborates with notable colleagues, including Robert Pinter and Jens Muehlsteff, who contribute to advancing the research and development of radar technologies within their organization. Their teamwork fosters an environment of innovation that has the potential to revolutionize medical diagnostics and patient monitoring.

Conclusion

Jeroen A J Thijs exemplifies the spirit of innovation in the field of radar technology. His patented invention demonstrates a commitment to improving healthcare solutions through advanced engineering. As his career progresses at Koninklijke Philips Corporation N.V., he is poised to make further significant contributions that could transform medical monitoring practices.